BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/12/2021 6:53:34 AM | Browse: 696 | Download: 1457
 |
Received |
|
2021-03-12 12:49 |
 |
Peer-Review Started |
|
2021-03-12 12:55 |
 |
First Decision by Editorial Office Director |
|
2021-04-17 05:07 |
 |
Return for Revision |
|
2021-04-17 05:07 |
 |
Revised |
|
2021-04-29 15:08 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2021-09-03 03:06 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2021-09-03 06:50 |
 |
Articles in Press |
|
2021-09-03 06:50 |
 |
Edit the Manuscript by Language Editor |
|
2021-09-15 10:24 |
 |
Typeset the Manuscript |
|
2021-10-08 00:22 |
 |
Publish the Manuscript Online |
|
2021-10-12 06:53 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pharmacology & Pharmacy |
| Manuscript Type |
Editorial |
| Article Title |
Biomarkers for gastrointestinal adverse events related to thiopurine therapy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Giulia Zudeh, Raffaella Franca, Gabriele Stocco and Giuliana Decorti |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Gabriele Stocco, PhD, Associate Professor, Department of Life Sciences, University of Trieste, via Fleming 22, Trieste 34127, Italy. stoccog@units.it |
| Key Words |
Thiopurines; Gastrointestinal adverse effects; Biomarkers; PACSIN2; RAC1; ITPA |
| Core Tip |
Adverse reactions to thiopurines are one of the main causes of treatment discontinuation or interruption. In addition to myelosuppression, approximately 5–20% of patients develop gastrointestinal toxicity; the identification of biomarkers to prevent and/or monitor these adverse reactions is important for the proactive management of long-term thiopurine therapy. In this editorial, we discuss evidence supporting the use of PACSIN2, RAC1 and ITPA genes, in addition to TPMT and NUDT15, as possible biomarkers of thiopurine-related gastrointestinal toxicity. |
| Publish Date |
2021-10-12 06:53 |
| Citation |
Zudeh G, Franca R, Stocco G, Decorti G. Biomarkers for gastrointestinal adverse events related to thiopurine therapy. World J Gastroenterol 2021; 27(38): 6348-6356 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i38/6348.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i38.6348 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.